INHALATIONAL ANTHRAX
Clinical trials for INHALATIONAL ANTHRAX explained in plain language.
Never miss a new study
Get alerted when new INHALATIONAL ANTHRAX trials appear
Sign up with your email to follow new studies for INHALATIONAL ANTHRAX, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study to test anthrax drug in bioterror attack scenario
Disease control Not yet recruitingThis study will evaluate how well the drug raxibacumab works and how safe it is for people who have symptoms of inhalational anthrax after a large-scale exposure, such as a bioterrorist attack. Up to 100 people of all ages, including pregnant women and children, who receive the d…
Matched conditions: INHALATIONAL ANTHRAX
Phase: PHASE4 • Sponsor: Emergent BioSolutions • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Emergency anthrax drug trial set to launch if outbreak strikes
Disease control Not yet recruitingThis study will test a medicine called AIGIV for people who have breathed in anthrax germs during a large-scale emergency. The goal is to see if the drug helps more people survive and to check for side effects. The study will only start if a major anthrax event happens, and it wi…
Matched conditions: INHALATIONAL ANTHRAX
Sponsor: Emergent BioSolutions • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC